Nutritional Intake and Gut Microbiome

Hallym University Kangnam Sacred Heart Hospital

Status

Completed

Conditions

Obesity, Childhood

Treatments

Diagnostic Test: Gut microbiome profiling

Study type

Observational

Funder types

Other

Identifiers

NCT03388411

Gut microbiome

Details and patient eligibility

About

Pediatric obesity has been increasing in prevalence, but concerns have been raised around the world because no treatment has been found. Recently, however, research on gut microbiome has begun to become a new alternative. It has been shown that changes in the microbiome in adults may induce obesity. However, the results on children are still scarce. Unlike adults, children have few external factors such as alcohol, tobacco, stress, and cancer, making them suitable for obesity-related gut microbiome studies. The investigators will use Illumina MiSeq platform for 16s rRNA metagenomics profiling in children. In this study, the investigators aimed to analyze the relationship between pediatric obesity, gut microbiome profile, blood biomarkers relevant to metabolic syndrome, and nutrient intake data.

Enrollment

61 patients

Sex

All

Ages

Under 12 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Obese children: Children ≥95 ‰ between age 7 and 12 years
Non-obese children: 5‰<BMI <85 ‰ for children between the ages of 7 and 12 years

Exclusion criteria

Taking antibiotics, probiotics, or steroids for a month before visit
Taking probiotics-like products including yogurt for seven days before visit
Having enteritis symptoms including diarrhea for a month before visit
Chronic heart disease, chronic bowel disease, chronic liver disease, chronic kidney disease, endocrine disease, genetic diseases or congenital metabolic disorder